NCT04257630 Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD Status COMPLETED Phase N/A
NCT04244825 Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF Status WITHDRAWN Phase PHASE2
NCT04233814 Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT04197791 Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT04187079 Immunopathologic Profiles and Blood Biomarkers in Patients With IPF Status COMPLETED Phase N/A
NCT04072315 Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ Status COMPLETED Phase PHASE2
NCT04071769 Genentech Xenon MRI Idiopathic Pulmonary Fibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04031690 Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients Status COMPLETED Phase N/A
NCT04030026 A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough Status COMPLETED Phase PHASE2
NCT04019080 Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden Status UNKNOWN Phase N/A
NCT04016181 The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study Status ENROLLING_BY_INVITATION Phase N/A
NCT03981406 Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase NA
NCT03979430 Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study Status COMPLETED Phase NA